Comparison of Quality of Life Between Breast Cancer Patients Treated With and Without Adjunctive Traditional Chinese Medicine in Taiwan

Author:

Chu Yeong-Ruey1ORCID,Kung Pei-Tseng123,Liu Liang-Chih3,Lin Chin-Yao4,Ou-Yang Fu5,Yue Chia-Herng6,Su Shan-Yu3,Chen Ying-Yu3,Wang Wen-Ching7,Kao Hui-Fen8,Chou Wen-Yu1,Tsai Wen-Chen1ORCID

Affiliation:

1. China Medical University, Taichung, Taiwan

2. Asia University, Taichung, Taiwan

3. China Medical University Hospital, Taichung, Taiwan

4. Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan

5. Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

6. Tung’s Taichung MetroHarbor Hospital, Taichung, Taiwan

7. Chi-Mei Medical Center, Tainan, Taiwan

8. Asia University Hospital, Taichung, Taiwan

Abstract

In Taiwan, breast cancer has the highest incidence among all cancers. Although adjunctive traditional Chinese medicine treatment (TCM) have been used to ameliorate the side effects or discomfort caused by cancer treatments, no study has focused on the assessment of the quality of life of patients undergoing adjunctive TCM treatments. This study compared the quality of life between breast cancer patients treated with and without adjunctive TCM. Questionnaires were collected from 7 hospitals with a Chinese medicine clinic in 2018 to 2019. Breast cancer patients who had cancer stages I, II, or III and also underwent resection surgery were included in the study. They were divided into 2 groups: patients receiving cancer treatments with adjunctive traditional Chinese medicine (TCM group) and those receiving cancer treatments without adjunctive traditional Chinese medicine (non-TCM group). A 1:1 matching was used to obtain the study participants. The EQ-5D questionnaire was used to assess the quality of life. Statistical analysis was performed using the t-test and ANOVA to compare the differences between variables. The conditional multiple regression model was applied to explore the factors associated with quality of life in breast cancer patients. A total of 543 participants were surveyed, and 450 participants were included in the study. The EQ-5D score of the TCM group (81.60 ± 11.67) was significantly higher than that of the non-TCM group (78.80 ± 13.10; P < .05). The results of a conditional multiple regression model showed that the TCM group had a higher (3.45 points) quality of life than non-TCM group ( P = .002) after adjusting for other related factors. After stratifying by cancer stage, patients with cancer stages II and III scored 5.58 and 4.35 points higher in the TCM group than did those in the non-TCM group ( P < .05). Breast cancer patients undergoing cancer treatment with adjunctive traditional Chinese medicine have a higher quality of life than those treated without adjunctive traditional Chinese medicine.

Funder

China Medical University, Taiwan

ministry of science and technology

Publisher

SAGE Publications

Subject

Complementary and alternative medicine,Oncology

Reference39 articles.

1. World Health Organization. Cancer. Accessed December 7, 2016. https://www.who.int/health-topics/cancer#tab=tab_2

2. Registry TTC. Cancer Survival Rates in Taiwan 2014-2018. Accessed May 30, 2021. http://tcr.cph.ntu.edu.tw/main.php?Page=A5B3

3. Therapeutic efficacy of traditional Chinese medicine, Shen-Mai San, in cancer patients undergoing chemotherapy or radiotherapy: study protocol for a randomized, double-blind, placebo-controlled trial

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3